Osteopenic bone cell response to strontium-substituted hydroxyapatite

被引:83
作者
Boanini, E. [1 ]
Torricelli, P. [2 ]
Fini, M. [2 ]
Bigi, A. [1 ]
机构
[1] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy
[2] Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Lab Preclin & Surg Studies, Bologna, Italy
关键词
IN-VITRO; OSTEOBLAST DIFFERENTIATION; DOPED HYDROXYAPATITE; OSTEOCLAST FORMATION; RANELATE; INTERLEUKIN-6; RESORPTION; OSTEOINTEGRATION; PROLIFERATION; BIOMATERIALS;
D O I
10.1007/s10856-011-4379-3
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Ionic substitution is a powerful tool to improve the biological performance of calcium phosphate based materials. In this work, we investigated the response of primary cultures of rat osteoblasts derived from osteopenic (O-OB) bone to strontium substituted hydroxyapatite (SrHA), and to hydroxyapatite (HA) as reference material, compared to normal (N-OB) bone cells. Strontium (Sr) and calcium (Ca) cumulative releases in physiological solution are in agreement with the greater solubility of SrHA than HA, whereas the differences between the two materials are levelled off in DMEM, which significantly reduced ion release. O-OB cells grown on SrHA exhibited higher proliferation and increased values of the differentiation parameters. In particular, Sr substitution increased the levels of proliferation, alkaline phosphatase, and collagen type I, and down-regulated the production of interleukin-6 of O-OB cells, demonstrating a promising future of SrHA in the treatment of bone lesions and defects in the presence of osteoporotic bone.
引用
收藏
页码:2079 / 2088
页数:10
相关论文
共 47 条
[1]
Strontium ranelate: A novel mode of action leading to renewed bone quality [J].
Ammann, P .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (Suppl 1) :S11-S15
[2]
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response [J].
Atkins, G. J. ;
Welldon, K. J. ;
Halbout, P. ;
Findlay, D. M. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (04) :653-664
[3]
Atsushi E, 2003, BIOMATERIALS, V24, P831
[4]
Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation In Vitro and In Vivo [J].
Axmann, Roland ;
Boehm, Christina ;
Kroenke, Gerhard ;
Zwerina, Jochen ;
Smolen, Josef ;
Schett, Georg .
ARTHRITIS AND RHEUMATISM, 2009, 60 (09) :2747-2756
[5]
Normal and osteopenic bone-derived osteoblast response to a biomimetic gelatin-calcium phosphate bone cement [J].
Bigi, A. ;
Panzavolta, S. ;
Sturba, L. ;
Torricelli, P. ;
Fini, M. ;
Giardino, R. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 78A (04) :739-745
[6]
Strontium-substituted hydroxyapatite nanocrystals [J].
Bigi, Adriana ;
Boanini, Elisa ;
Capuccini, Chiara ;
Gazzano, Massimo .
INORGANICA CHIMICA ACTA, 2007, 360 (03) :1009-1016
[7]
The dual role of IL-6-type cytokines on bone remodeling and bone tumors [J].
Blanchard, Frederic ;
Duplomb, Laurence ;
Baud'huin, Marc ;
Brounais, Benedicte .
CYTOKINE & GROWTH FACTOR REVIEWS, 2009, 20 (01) :19-28
[8]
Ionic substitutions in calcium phosphates synthesized at low temperature [J].
Boanini, E. ;
Gazzano, M. ;
Bigi, A. .
ACTA BIOMATERIALIA, 2010, 6 (06) :1882-1894
[9]
Dual effect of strontium ranelate:: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro [J].
Bonnelye, Edith ;
Chabadel, Anne ;
Saltel, Frederic ;
Jurdic, Pierre .
BONE, 2008, 42 (01) :129-138
[10]
Calvo-Fernández T, 2010, EUR CELLS MATER, V20, P260